09:47 AM EST - InMed Pharmaceuticals Inc. : Announced that it is working with the Almac Group (U.K.) on a proprietary approach to augment current biosynthesis-based methods for cannabinoid production. InMed Pharmaceuticals Inc.
shares T.IN are trading up $0.005 at $0.21.
